文献速递重症综合管理与镇静镇痛

患者与代理人对重症前身体功能评估的一致性

Agreement Between Patient and Surrogate Assessments of Pre-Critical Illness Physical Function.
PubMed 文献 · Crit Care Med · 2026-01-14
一句话结论在重症前身体功能评估中,患者与代理人问卷一致性仅为中等(ICC 0.43–0.52),且患者自评功能优于代理人评估,尤其在功能较低时。

这项前瞻性观察队列在三级医疗中心纳入75对患者-代理人,评估入ICU前4周身体功能,使用vSPPB、SARC-F和FRAIL问卷。患者与代理人在三个问卷上的组内相关系数分别为0.52、0.43和0.45,呈中等一致性;Spearman相关系数分别为0.60、0.46和0.53(p<0.001)。患者报告的功能优于代理人,尤其在功能较低时。作者认为需要进一步开发评估重症前身体功能的工具。

要点

  • 在75对患者-代理人中,vSPPB的ICC为0.52(95%CI 0.31-0.69),SARC-F为0.43(95%CI 0.22-0.60),FRAIL为0.45(95%CI 0.24-0.63),一致性仅为中等。
  • 患者与代理人评分在vSPPB、SARC-F和FRAIL上的Spearman相关系数分别为0.60、0.46和0.53(p<0.001),呈中度相关。
  • 患者报告的身体功能优于代理人评估,尤其在功能较低时。
  • 作者认为,需要进一步开发工具来评估重症前身体功能。

适用人群与场景

  • 因呼吸衰竭、休克和/或脓毒症接受治疗的患者及其精心选择的代理人。

研究设计与关键结果

  • 研究类型为前瞻性观察队列,在三级医疗中心纳入75对患者-代理人。
  • 患者中位年龄61岁(IQR 52-69),Charlson合并症指数2(IQR 1-2),基线日常生活活动能力障碍评分3(IQR 1-7);大多数代理人为配偶(68%),平均每天与患者相处20小时(IQR 12-24小时/天)。
  • 主要结局:患者与代理人在vSPPB、SARC-F和FRAIL复合评分上的一致性分别为ICC 0.52(95%CI 0.31-0.69)、ICC 0.43(95%CI 0.22-0.60)和ICC 0.45(95%CI 0.24-0.63)。
  • 次要结局:患者与代理人评分在vSPPB、SARC-F和FRAIL上的Spearman相关系数分别为0.60、0.46和0.53(p<0.001)。
  • 患者报告的身体功能优于代理人,尤其在功能较低时。

证据类型、等级与局限

  • 证据类型:前瞻性观察队列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需要进一步开发工具来评估重症前身体功能。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: We know little of the impact that pre-critical illness physical function plays in the recovery from critical illness. The agreement between patients and surrogates on physical function questionnaires is unclear.

DESIGN, SETTING, AND PATIENTS: Prospective observational cohort conducted at a tertiary medical center. We enrolled patient-participants who were treated for respiratory failure, shock, and/or sepsis and their well-chosen surrogates.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We assessed patient-participant physical function anchored on the 4 weeks before admission using the virtual Short Physical Performance Battery (vSPPB); Strength, Assistance in Walking, Rising from a Chair, Climbing Stairs, Falls (SARC-F) questionnaire; and Fatigue, Resistance, Ambulation, Illness, and Loss of weight (FRAIL) questionnaire completed by both patient and surrogate participants. The primary outcome was agreement between patient and surrogate responses on composite scores from each questionnaire. Secondary outcomes included correlations between patient and surrogate responses, and the relationship between surrogate and patient responses. We enrolled 75 patient-surrogate dyads. Patient-participants had a median (interquartile range) age of 61 (52-69), a Charlson Comorbidity Index of 2 (1-2), and a baseline activities of daily living disability score of 3 (1-7). Most surrogates were spouses (68%), who spent an average of 20 hours per day (12-24 hr/d) with patients. We found fair agreement between patient and surrogate scores on the vSPPB (intraclass correlation coefficient [ICC], 0.52; 95% CI, 0.31-0.69), SARC-F (ICC, 0.43; 95% CI, 0.22-0.60), and FRAIL (ICC, 0.45; 95% CI, 0.24-0.63). We found moderate correlation between patient and surrogate scores on the vSPPB, SARC-F, and FRAIL (Spearman r 0.60, 0.46, and 0.53, respectively [ p < 0.001]).

CONCLUSIONS: We found fair agreement and moderate correlation on previously validated self-report questionnaires of physical function. Patients reported better function than their surrogates particularly at lower levels of function. Our findings highlight the need for further development of tools to assess pre-critical illness physical function.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Gordon JI, So PT, McElroy J, et al. Agreement Between Patient and Surrogate Assessments of Pre-Critical Illness Physical Function. Crit Care Med. 2026. PMID: 41532817. doi:10.1097/CCM.0000000000007030

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。